IBIS Therapeutics

IBIS Therapeutics (Tampa, FL) tackles the problem of therapeutic efficacy using a unique AI engine capable of predicting absorption, distribution, metabolism, excretion and toxicity to identify the best drug candidates from a quarter billion small molecules. IBIS’s first to market product will focus on COVID-19 and inflammation which enables a cost-effective drug discovery process to investigate every protein in the SARS-CoV-2 viral proteome for drug candidates in a few months compared to the time required for traditional compound discovery.

IBIS Therapeutics (Tampa, FL) tackles the problem of therapeutic efficacy using a unique AI engine capable of predicting absorption, distribution, metabolism, excretion and toxicity to identify the best drug candidates from a quarter billion small molecules. IBIS’s first to market product will focus on COVID-19 and inflammation which enables a cost-effective drug discovery process to investigate every protein in the SARS-CoV-2 viral proteome for drug candidates in a few months compared to the time required for traditional compound discovery.